Sab Biotherapeutics Stock Technical Analysis
| SABSW Stock | USD 0.07 0.01 9.12% |
As of the 25th of November, SAB Biotherapeutics owns the Standard Deviation of 20.27, market risk adjusted performance of (10.83), and Semi Deviation of 11.0. In respect to fundamental indicators, the technical analysis model makes it possible for you to check possible technical drivers of SAB Biotherapeutics, as well as the relationship between them. Please validate SAB Biotherapeutics mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if SAB Biotherapeutics is priced fairly, providing market reflects its prevailing price of 0.073 per share. As SAB Biotherapeutics appears to be a penny stock we also recommend to double-check its total risk alpha numbers.
SAB Biotherapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as SAB, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SABSAB |
SAB Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
SAB Biotherapeutics Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of SAB Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
SAB Biotherapeutics Trend Analysis
Use this graph to draw trend lines for SAB Biotherapeutics. You can use it to identify possible trend reversals for SAB Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual SAB Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.SAB Biotherapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for SAB Biotherapeutics applied against its price change over selected period. The best fit line has a slop of 0.0009 , which means SAB Biotherapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.03, which is the sum of squared deviations for the predicted SAB Biotherapeutics price change compared to its average price change.About SAB Biotherapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of SAB Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of SAB Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on SAB Biotherapeutics price pattern first instead of the macroeconomic environment surrounding SAB Biotherapeutics. By analyzing SAB Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of SAB Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to SAB Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 44.99 | 26.29 | 42.24 | 26.62 | Receivables Turnover | 7.6 | 4.3 | 3.87 | 3.16 |
SAB Biotherapeutics November 25, 2024 Technical Indicators
Most technical analysis of SAB help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for SAB from various momentum indicators to cycle indicators. When you analyze SAB charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1758 | |||
| Market Risk Adjusted Performance | (10.83) | |||
| Mean Deviation | 13.4 | |||
| Semi Deviation | 11.0 | |||
| Downside Deviation | 18.37 | |||
| Coefficient Of Variation | 461.45 | |||
| Standard Deviation | 20.27 | |||
| Variance | 410.76 | |||
| Information Ratio | 0.2103 | |||
| Jensen Alpha | 4.43 | |||
| Total Risk Alpha | 1.19 | |||
| Sortino Ratio | 0.232 | |||
| Treynor Ratio | (10.84) | |||
| Maximum Drawdown | 102.82 | |||
| Value At Risk | (24.13) | |||
| Potential Upside | 52.09 | |||
| Downside Variance | 337.32 | |||
| Semi Variance | 120.99 | |||
| Expected Short fall | (23.35) | |||
| Skewness | 1.14 | |||
| Kurtosis | 2.24 |
Additional Tools for SAB Stock Analysis
When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.